| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.18 | 6e-07 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-06 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-05 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-05 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.13 | 6e-05 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.22 | 7e-05 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 9e-05 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |